TA 60
Latest Information Update: 28 Nov 1994
At a glance
- Originator Taisho Pharmaceutical
- Class Antirheumatics; Nonsteroidal anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders